Fresh analysis reveals that individuals who come off new weight-loss injections like semaglutide or tirzepatide tend to recover shed pounds at a significantly accelerated pace than those who end traditional lifestyle programs.
Published data in a leading health publication shows that while obese individuals can lose substantial amounts of their body weight while using the jabs, the weight returns at an estimated rate of 0.8 kg per month upon discontinuation.
"People purchasing such drugs need to be aware of the risk of quick weight regain when the medication is stopped," warns expert Dr. Susan Jebb.
Such speed of regain implies a return to original weight within about one and a half years.
Weighing Approaches
The study, which examined dozens of trials involving thousands of participants, compared the results of these new drugs with older methods.
Scientists emphasize that people who shed pounds through diet and exercise typically see a slower creep back—around 100 grams monthly—once they finish.
Understanding the Rapid Rebound
Doctors believe the mode of action of the drugs accounts for the accelerated rebound.
These medications copy a natural hormone called GLP-1, which moderates feelings of fullness.
"Artificially providing GLP-1 levels several times higher than normal could lead to the system to produce less of its own natural hormone, and could reduce responsiveness to its actions," noted Dr. Adam Collins, a dietetics expert.
"Discontinuation of this GLP-1 'fix' leads to appetite is unsuppressed, making binge eating a significant risk."
A Chronic Disease?
Medical guidelines suggest the jabs for individuals with weight-linked medical conditions, alongside prescribed lifestyle changes.
Many experts say that, due to the likelihood of weight regain, the therapy is often ongoing.
This view is supported by drug manufacturers, who note that the results "emphasize the chronic character of excess weight," similar to managing conditions like diabetes.
Patient Accounts
Individuals who have stopped the medication explain a powerful resurgence of hunger.
"I experienced a trigger flipping and you become starving," recalled an individual.
This difficulty is compounded if patients have not established sustainable lifestyle or habit changes during therapy.
Significant Use
Survey data indicate that a significant number of adults in the UK have used these injections in the past year, with interest being substantial.
- Use is higher among women compared to men.
- The 40s and 50s demographic shows the greatest usage rates.
- A large proportion access the drugs through private prescriptions rather than public health services.
In conclusion, researchers stress that while these medications are effective tools for weight loss, they are not a permanent solution and long-term success hinges on combined lifestyle management.
